Clàudia Fortuny Guasch

Role of Magnetic Resonance Imaging and Cranial Ultrasonography in Congenital Cytomegalovirus Infection

Daniel Blázquez‐Gamero, María Soriano‐Ramos, Ana Martı́nez de Aragón et al. · The Pediatric Infectious Disease Journal · 2019 · 37 citations

Veterinary Medicine, Infectious Diseases, Radiology +14

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

Pauline Amuge, Abbas Lugemwa, Ben Wynne et al. · The Lancet HIV · 2022 · 31 citations · Full text

Pharmacy, Infectious Diseases, Pediatrics +15

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

Anna Turkova, Hylke Waalewijn, Man K. Chan et al. · The Lancet HIV · 2022 · 24 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial

Alexandra Compagnucci, Man K. Chan, Yacine Saïdi et al. · EClinicalMedicine · 2023 · 16 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Double-Blind, Placebo-Controlled Study of Bezlotoxumab in Children Receiving Antibacterial Treatment for <i>Clostridioides difficile</i> Infection (MODIFY III)

Thomas J. Sferra, Tomáš Merta, Michael Neely et al. · Journal of the Pediatric Infectious Diseases Society · 2023 · 12 citations · Full text

Pharmacy, Pediatrics, Pharmacokinetics +14